Crux Biomedical Acquired by Volcano Corporation for $36M
December 5, 2012- Share:
VC-backed Crux Biomedical has agreed to be acquired by Volcano Corporation, a developer of medical devices and technologies used to treat coronary and peripheral vascular disease. Both companies have focused their attention on treating issues related to the human vascular system. Crux, a Menlo Park, Calif.-based company, is responsible for creating an innovative device used for the treatment of pulmonary embolisms. Per the agreement’s terms, Volcano will pay $36 million in cash at the time of closing. Exiting investors include Alloy Ventures, Three Arch Partners, Emergent Medical Partners and angel investor Thomas Fogarty, M.D.
Surgical Devices
Manufacturing
Menlo Park, CA
- Share:
-
-
-
-